Search research articles
Contact Us
Filters
Showing results (151-160 of 234) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nuclear morphometry and prognosis in favorable histology Wilms' tumor: A prospective reevaluation
N E Breslow, A W Partin, B R Lee, et al.
The Journal of Urology
|
March 1, 1995
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease
M J Carmichael, R W Veltri, A W Partin, et al.
Urology
|
July 1, 1994
Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience
L R Kavoussi, R G Moore, A W Partin, et al.
The Journal of Urology
|
November 1, 1992
A quantitative histological analysis of the dilated ureter of childhood
B R Lee, A W Partin, J I Epstein, et al.
Cancer
|
June 28, 2000
Identification and characterization of circulating prostate carcinoma cells
Z P Wang, M A Eisenberger, M A Carducci, et al.
Urology
|
February 5, 1999
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial
B Djavan, S Shariat, M Fakhari, et al.
Urology
|
November 1, 1994
Concordance rates for benign prostatic disease among twins suggest hereditary influence
A W Partin, W F Page, B R Lee, et al.
The Journal of Urology
|
April 1, 1989
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia
J P Weber, J E Oesterling, C A Peters, et al.
Urology
|
December 1, 1996
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age
A W Partin, W J Catalona, P C Southwick, et al.
The Journal of Urology
|
November 1, 1989
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis
A W Partin, A C Walsh, R V Pitcock, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 234) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Nuclear morphometry and prognosis in favorable histology Wilms' tumor: A prospective reevaluation
N E Breslow, A W Partin, B R Lee, et al.
The Journal of Urology
|
March 1, 1995
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 disease
M J Carmichael, R W Veltri, A W Partin, et al.
Urology
|
July 1, 1994
Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience
L R Kavoussi, R G Moore, A W Partin, et al.
The Journal of Urology
|
November 1, 1992
A quantitative histological analysis of the dilated ureter of childhood
B R Lee, A W Partin, J I Epstein, et al.
Cancer
|
June 28, 2000
Identification and characterization of circulating prostate carcinoma cells
Z P Wang, M A Eisenberger, M A Carducci, et al.
Urology
|
February 5, 1999
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial
B Djavan, S Shariat, M Fakhari, et al.
Urology
|
November 1, 1994
Concordance rates for benign prostatic disease among twins suggest hereditary influence
A W Partin, W F Page, B R Lee, et al.
The Journal of Urology
|
April 1, 1989
The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia
J P Weber, J E Oesterling, C A Peters, et al.
Urology
|
December 1, 1996
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age
A W Partin, W J Catalona, P C Southwick, et al.
The Journal of Urology
|
November 1, 1989
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis
A W Partin, A C Walsh, R V Pitcock, et al.
Page
of 24